Russia vs Other Regulators
Overview
Russia's regulatory framework shares structural similarities with the European system (four risk classes, risk-based classification, technical documentation requirements aligned with EU MDR Annex II) but has several unique features that require dedicated compliance planning.
Key comparison
| Feature | Russia (RZN) | EU (MDR) | USA (FDA) | Australia (TGA) |
|---|---|---|---|---|
| Classes | I, IIa, IIb, III | I, IIa, IIb, III | I, II, III | I, IIa, IIb, III |
| Registration database | GRLS | EUDAMED | FDA 510(k)/PMA database | ARTG |
| Local representative required | Yes — RUS REP | Yes — EUAP (for non-EU) | Yes — US Agent | Yes — Australian Sponsor |
| Clinical testing in-country | Often required | Generally not | Not required | Not required |
| QMS inspection | Mandatory IIa sterile, IIb, III | Via Notified Body | Via FDA inspection | Via TGA/MDSAP |
| Multi-country route | EAEU (5 countries) | CE mark (EU/EEA) | No equivalent | No equivalent |
| Language | Russian mandatory | Local language | English | English |
Key differences for manufacturers familiar with EU MDR
- Local clinical testing is a significant additional requirement in Russia, particularly for Class IIb and III devices with no Russian-registered equivalent.
- Russian-language translation of all documentation is mandatory — there is no flexibility on this point.
- Two-phase review process is different from the EU conformity assessment model — Russia uses a state expert review system rather than Notified Body certification.
- EAEU transition means manufacturers must eventually migrate to EAEU rules regardless of existing national registrations.
IMDRF membership
Russia is a member of the International Medical Device Regulators Forum (IMDRF). Russia chaired IMDRF in 2019. IMDRF guidance documents (including GHTF studies) are considered in Russian regulatory development, though implementation is not automatic.
Official source
IMDRF: imdrf.org